Preliminary Efficacy of Implementing a Program of Exercise Medicine for Men on Prostate Cancer Active Surveillance - a Pilot Study

Recruiting

• Conditions: Prostate cancer; Cancer - Prostate

• Registration Number: ACTRN12615001068550
• Lead Sponsor: Edith Cowan University Exercise Medicine Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

1) Be within 1 year of diagnosis of prostate cancer (clinical state as T1C and T2, Gleason score smaller than or equal to 6 (or as determined by treating clinician) and under 3 biopsy cores invaded with prostate cancer, PSA < 10ng/ml and PSA density < .2ng/ml) and undergoing active surveillance
2) Have physician consent
3) Willing to be randomised
4) Able to read and understand English

Exclusion Criteria

1) Received former therapy for prostate cancer
2) Not fit for curative treatment
3) Already performing regular exercise defined as undertaking structured resistance and aerobic training two or more times per week within the past 3 months
4) Any acute illness, musculoskeletal, cardiovascular or neurological disorder that could inhibit a participant's ability to participate in the exercise program or put them at risk of injury or illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility assessed by recruitment, retention and exercise adherence rates[Baseline, 3 months and 6 months after randomisation];Muscle strength assessed by 1-RM for the leg press and chest press[Baseline, 3 months and 6 months after randomisation]